First steps to neutralizing Zika: How highly potent antibody neutralizes Zika infection discovered

November 24, 2016
C10 antibody (purple) visualized to be interacting with the Zika virus coat (green). Credit: Victor Kostyuchenko, Duke-NUS Medical School

As Zika spreads throughout the world, the call for rapid development of therapeutics to treat Zika rings loud and clear. Taking a step further in identifying a possible therapeutic candidate, a team of researchers at Duke-NUS Medical School (Duke-NUS), in collaboration with scientists from the University of North Carolina, have discovered the mechanism by which C10, a human antibody previously identified to react with the Dengue virus, prevents Zika infection at a cellular level.

Previously, C10 was identified as one of the most potent antibodies able to neutralise Zika . Now, Associate Prof Lok Shee-Mei and her team at the Emerging Infectious Disease Programme of Duke-NUS have taken it one step further by determining how C10 is able to prevent Zika infection.

To infect a cell, particles usually undergo two main steps, docking and fusion, which are also common targets for disruption when developing viral therapeutics. During docking, the identifies specific sites on the cell and binds to them. With Zika infection, docking then initiates the cell to take the virus in via an endosome - a separate compartment within the cell body. Proteins within the virus coat undergo structural changes to fuse with the membrane of the endosome, thereby releasing the into the cell, and completing the fusion step of infection.

Using a method called cryoelectron microscopy, which allows for the visualisation of extremely small particles and their interactions, the team visualised C10 interacting with the Zika virus under different pHs, so as to mimic the different environments both the antibody and virus will find themselves in throughout infection. They showed that C10 binds to the main protein that makes up the Zika virus coat, regardless of pH, and locks these proteins into place, preventing the structural changes required for the fusion step of infection. Without fusion of the virus to the endosome, viral DNA is prevented from entering the cell, and infection is thwarted.

"Hopefully, these results will further accelerate the development of C10 as a Zika therapy to combat its effects of microcephaly and Guillain-Barré syndrome. This should emphasise the need for further studies of the effect of C10 on Zika infection in animal models," commented Dr Lok.

"By defining the structural basis for neutralization, these studies provide further support for the idea that this antibody will protect against Zika infection, potentially leading to a new therapy to treat this dreaded disease," says Ralph Baric, PhD, professor in the Department of Epidemiology at UNC's Gillings School of Global Public Health.

These findings suggest that C10 may be developed as a therapy for Zika infection, and should be further explored. In addition, disrupting fusion with C10 may prove to be more effective in preventing Zika infection compared with therapies that attempt to disrupt docking. This is because the fusion step is critical for Zika infection, while the virus may develop other mechanisms to overcome disruptions to the docking step. With the call for rapid development of Zika therapies, C10 has emerged as a front runner to answer this call.

Published on 24 November 2016 in Nature Communications, this research is supported by the Singapore Ministry of Education Tier 3 Grant (MOE2012-T3-1-008), the National Research Foundation Investigatorship Award (NRF-NRFI2016-01 to Lok Shee-Mei), Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore, and National Institute of Health (USA) AID Research Grants (AI100625, AI107731 to Ralph S. Baric).

Explore further: Research provides clues to how Zika virus breaches the placental barrier

More information: Nature Communications, DOI: 10.1038/NCOMMS13679

Related Stories

Zika virus: Five things to know

February 8, 2016

A concise "Five things to know about.... Zika virus infection" article for physicians highlights key points about this newly emerged virus in CMAJ (Canadian Medical Association Journal)

Researchers solve the structure of the Zika virus helicase

May 20, 2016

A team led by researchers from Tianjin University (P.R. China) has solved the structure of the Zika virus helicase, which is a key target for antiviral development. The research is published in Springer's journal Protein ...

Zika Virus in the Southeast

October 3, 2016

As of the end of July 2016, there have been 1,658 cases of Zika virus infections diagnosed in the United States. It is believed that most of these infections were contracted outside the United States. While the Zika virus ...

Recommended for you

Binge drinking may quickly lead to liver damage

January 23, 2017

Alcohol consumed during just seven weeks of intermittent binge drinking harms the liver in ways that more moderate daily drinking does not, according to researchers at UC San Francisco.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.